skip
net ir
Japanese
What's New

4502 Takeda Pharmaceutical Company Limited
President and Chief Executive Officer Christophe Weber
Meeting regarding Acquisition of Shire plc by Takeda
8252 MARUI GROUP CO., LTD.
Hiroshi Aoi President and Representative Director, Representative Executive Officer
MARUI IR DAY 2018
4503 Astellas Pharma Inc.
President and CEO Kenji Yasukawa, Ph.D
R&D Meeting
8604 Nomura Holdings, Inc.
Group CEO Koji Nagai
Nomura Investment Forum 2018
8630 Sompo Holdings, Inc.
President(Group CEO) Kengo Sakurada
Progress of Mid-term Management Plan and Direction of Management Strategy
8766 Tokio Marine Holdings, Inc.
President and Group CEO Tsuyoshi Nagano
Mid-Term Business Plan "To Be a Good Company 2020" FY2018 Business Plan Update
4536 Santen Pharmaceutical Co., Ltd.
President & Chief Operating Officer (COO) Shigeo Taniuchi
Investor Meeting on Q2 FY2018 Results
4507 SHIONOGI & CO., LTD.
Isao Teshirogi, Ph.D. President and CEO
1st Half of Fiscal 2018 Financial Results
4502 Takeda Pharmaceutical Company Limited
President and Chief Executive Officer Christophe Weber
Earnings Conference for the 2nd Quarter of Fiscal Year 2018
7013 IHI Corporation
President and Chief Executive Officer Tsugio Mitsuoka
Financial Results for Second Quarter FY2018 (for the year ending March 31, 2019)
8604 Nomura Holdings, Inc.
CFO Takumi Kitamura
Second Quarter Operating Results for Fiscal Year Ending March 2019
4503 Astellas Pharma Inc.
President and CEO Kenji Yasukawa, Ph.D
Q2/FY2018 FINANCIAL RESULTS ENDED SEPTEMBER 30, 2018
4502 Takeda Pharmaceutical Company Limited
Christophe Weber
President and Chief Executive Officer
TAKEDA R&D INVESTOR DAY 2018
8630 Sompo Holdings, Inc.
Mike McGuire Sompo International Holdings CFO
Sompo International Overview
3659 NEXON Co., Ltd.
President and Chief Executive Officer Owen Mahoney
Investor Presentation Q2 2018
4578 Otsuka Holdings Co., Ltd.
President and Representative Director, CEO Tatsuo Higuchi
FY2018 Half Year Consolidated Financial Results (Six Months Ended June 30, 2018)
4507 SHIONOGI & CO., LTD.
Takuko Sawada Director, Executive Vice President
1st Quarter of Fiscal 2018 Financial Results Conference Call
4523 Eisai Co., Ltd.
Representative Corporate Officer and CEO Haruo Naito
Q2 FY2018 (Fiscal Year Ending March 31, 2019) Financial Results Presentation
4502 Takeda Pharmaceutical Company Limited
President and Chief Executive Officer Christophe Weber
Conference Call for the Announcement of 1st Quarter Financial Results for Fiscal Year 2018
4536 Santen Pharmaceutical Co., Ltd.
Chairman & Chief Executive Officer (CEO) Akira Kurokawa
Medium-Term Plan (MTP2020) Aiming for Continuous Contribution to Ophthalmic Treatment
8604 Nomura Holdings, Inc.
Group Co-COO Toshio Morita
Investor Day
8766 Tokio Marine Holdings, Inc.
President and Group CEO Tsuyoshi Nagano
New Mid-Term Business Plan "To Be a Good Company 2020"
8630 Sompo Holdings, Inc.
President(Group CEO) Kengo Sakurada
Progress of Mid-term Management Plan
4503 Astellas Pharma Inc.
President and CEO Kenji Yasukawa, Ph.D.
STRATEGIC PLAN 2018
4507 SHIONOGI & CO., LTD.
Isao Teshirogi, Ph. D. President and CEO
FY 2017 Financial Results (April 2017-March 2018)
4578 Otsuka Holdings Co., Ltd.
Executive Director, Corporate Finance Yuko Makino
FY2018 Q1 Consolidated Financial Results
4502 Takeda Pharmaceutical Company Limited
President and Chief Executive Officer
Christophe Weber
Conference for the Announcement of "Financial Results for Fiscal Year 2017"
4536 Santen Pharmaceutical Co., Ltd.
Chairman & Chief Executive Officer (CEO) Akira Kurokawa
Investor Meeting on FY2017 Results and FY2018 Forecasts
4502 Takeda Pharmaceutical Company Limited
Christophe Weber President and CEO
Takeda to Acquire Shire-Accelerating Takeda's Transformation to Deliver More for Patients
4502 Takeda Pharmaceutical Company Limited
President and CEO
Christophe Weber
Takeda to Acquire Shire-Accelerating Takeda's Transformation to Deliver More for Patients

Precautions in use
Nomura IR assumes no responsibility for correctness, validity or any other nature of the contents on this server.
No act such as alteration, modification or addition to the contents is permitted.
Since the contents on this server are not intended to solicit investment, our company has no liability for any trouble related to investment made by any audience based on the contents of this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity or any other nature of information, including its format and details, obtained from any site linked from our site.

up
Download Plug-in
Get Adobe Reader
Windows Media Player
Real Player
Copyright (c) 2004 Nomura Investor Relations Co., Ltd. All Rights Reserved.
NIR